Prescribed Drugs Containing Nitrogen Heterocycles: an Overview Cite This: RSC Adv., 2020, 10, 44247 Majid M

Total Page:16

File Type:pdf, Size:1020Kb

Prescribed Drugs Containing Nitrogen Heterocycles: an Overview Cite This: RSC Adv., 2020, 10, 44247 Majid M RSC Advances View Article Online REVIEW View Journal | View Issue Prescribed drugs containing nitrogen heterocycles: an overview Cite this: RSC Adv., 2020, 10, 44247 Majid M. Heravi * and Vahideh Zadsirjan Heteroatoms as well as heterocyclic scaffolds are frequently present as the common cores in a plethora of active pharmaceuticals natural products. Statistically, more than 85% of all biologically active compounds are heterocycles or comprise a heterocycle and most frequently, nitrogen heterocycles as a backbone in their complex structures. These facts disclose and emphasize the vital role of heterocycles in modern drug design and drug discovery. In this review, we try to present a comprehensive overview of top Received 28th October 2020 prescribed drugs containing nitrogen heterocycles, describing their pharmacological properties, medical Accepted 23rd November 2020 applications and their selected synthetic pathways. It is worth mentioning that the reported examples are DOI: 10.1039/d0ra09198g actually limited to current top selling drugs, being or containing N-heterocycles and their synthetic rsc.li/rsc-advances information has been extracted from both scientific journals and the wider patent literature. Creative Commons Attribution 3.0 Unported Licence. 1. Introduction chloroquinine, azidothymidine and anti-pyrine. Furthermore, most of the vitamins, nucleic acid, enzymes, co-enzymes, hormones, and 13 Medicinal and pharmaceutical chemistry are disciplines at the alkaloids contain N-based heterocycles as scaffolds. intersection of chemistry, especially synthetic organic chemistry, and Due to exhibiting diverse biological activities, nitrogen pharmacology and various other biological specialties, leading to the heterocyclic compounds have always been attractive targets to design, chemical synthesis and development of bio-active molecules, synthetic organic chemists. Since, several of them are prevalent for being approved as prescribed and market purchasable pharma- in natural products, especially alkaloids, they have received ceutical agents. Heterocyclic compounds, as the most important much attention of synthetic community, especially those who This article is licensed under a 14 organic compounds, are frequently present in molecules of interest are engaged with the total synthesis of natural products. As in medicinal chemistry.1 Among them, nitrogen containing hetero- a result, the vast number of nitrogen heterocyclic compounds cycles are of great importance to life science, since they are abundant have been under continuous investigations from different Open Access Article. Published on 15 December 2020. Downloaded 10/6/2021 4:16:25 PM. in nature, existing as subunits in several natural products, for points of view thus, found applications in pharmaceutical 15,16 example vitamins, hormones and antibiotics. Some representative research and drug discovery. Recently, N-based heterocycles alkaloids and other nitrogen containing natural products, showing have attracted much interest of medicinal chemists and biolo- diverse biological activities, and several of them are even prescribed gists due to broad range of biological activities and plentiful 17 drugs such as serotonin,2 thiamine, which is also called vitamin B1,3 applications in the extensive elds of pharmacy. atropine,4 notorious morphine,5 codeine, (greater benetmaybe FDA databases has revealed that about 60% of unique small- gained when it is combined with acetaminophen or a nonsteroidal molecule drugs, comprise N-based heterocycles, showing the anti-inammatory drug (NSAID) such as aspirin or ibuprofen),6 structural signicance of N-based heterocycles in drug design 18 papaverine,7 coniine,8 caffeine9 and nicotine.10 and drug discovery. The prevalence of N-heterocyles in bio- Furthermore, N-based heterocycles are indispensable diet logically active compounds can be attributed to their stability components such as thiamin (vitamin B1), riboavin (vitamin B2), and operational efficiency in human body and the fact of that pyridoxol (vitamin B6), nicotinamide (vitamin B3).11,12 Nitrogen- the nitrogen atoms are readily bonded with DNA through containing heterocyclic compounds are not only present as the hydrogen bonding. As a matter of fact, anti-cancer activities of backbone in several biologically active natural products used as N-based heterocycle agents are largely due to their tendency of 19 traditional medications or approved prescribed drugs, but some of interaction with DNA via hydrogen bonding. their synthetic derivatives in different sizes, nowadays are prescribed In 2014 Njardarson et al. published the rst comprehensive 16 and market purchasable drugs. The most famous are, diazepam, analysis of the nitrogen based heterocycles. This analysis isoniazid, chlorpromazine, metronidazole, barbituric acid, captopril, showed that indeed about 60% of small-molecule drugs contain a N-based heterocycle as common architectural cores. In 2011, Baumann et al. presented an overview of the key pathways to the Department of Chemistry, School of Science, Alzahra University, PO Box 1993891176, synthesis of the best-selling ve-membered ring heterocyclic Vanak, Tehran, Iran. E-mail: [email protected]; [email protected]; Fax: medications regardless of their kinds of heterocycles.20 In the +98 21 88041344; Tel: +98 21 88044051 This journal is © The Royal Society of Chemistry 2020 RSC Adv.,2020,10,44247–44311 | 44247 View Article Online RSC Advances Review following, in 2013 the same authors presented an overview on common of such pharmaceuticals, classifying them in accor- the synthetic pathways to the best selling drugs comprising six- dance of their size of N-based heterocycles, in, four, ve, six, and membered heterocyclic systems.21 In 2018, Ramazani and co- seven-membered rings. Moreover, the fused, bridged bicyclic workers15 presented the recent advances in nitrogen-based nitrogen heterocycles have been also covered. heterocyles as useful cancer chemotherapy agents. Cancer is one of the foremost roots of death, globally. It is the result of mutation of the cells which regulate the genes and protein. 2. Synthesis of nitrogen prescribed Although, surgery and radiotherapy are the current therapy drugs having several drugs are also used as anticancer agents in spite of their undesired side effects. Some analogues of new isosteviol-fused 2.1 Four-membered heterocycles pyrazoline, ursolic acid linked triazole or D-ribose linked exhibit In general antimicrobial drugs are recognized as bacteriostatic (i.e., 22 anticancer activity at the nanomolar range. Furthermore tetracyclines, sulfonamides) and as antibacterial (i.e., penicillin). showing segment resemblance with histidine imidazole mole- Beta-lactam antibiotics are categorized to four groups. They are cule N-based-heterocycles can be linked with protein molecules penicllins, cephalosporins, monobactams, and carbapenems. They ff more easily than some other heterocyclic sca olds, thus, these all comprise a four-membered beta-lactam ring that is essential for types of N-heterocyclics are the most promising drugs for being displaying their antibactericidal activities. In 1929, penicillin was 23 designed and screened as anti-cancer drugs. We are interested explored by Sir Alexander Fleming, who observed that one of his 24 in heterocyclic chemistry, especially those containing nitrogen experimental cultures of staphylococcus was polluted with fungus 25–33 atom. that caused the bacteria to lyse.43,44 Since fungus belonged to the 24 We are interested in heterocyclic chemistry, especially family penicillium, he called this bactericidal substance penicillin. 25–33 those containing nitrogen atom. In recent years, our group A decade later, a research group at Oxford University could isolated has also focused on the applications of name reactions in the a crude substance built of a few low-molecular substances that were Creative Commons Attribution 3.0 Unported Licence. total synthesis of natural products containing nitrogen hetero- named penicillins (F, G, K, O, V, X). Among the various penicillins 34–42 cycles, showing diverse biological activities. Armed with (F,G,K,O,V,X),penicillinG(benzylpenicillin), was found the most these experiences, in this review we try to highlight the medical effective. Since then, penicillin G, is used as an antibiotic to treat usages and selected synthetic pathways of approved and market a number of bacterial infections.45 purchasable prescribed medications, containing nitrogen There are three main and remarkable stages to the biosyn- based-heterocycles. Having collected and categorized of about thesis of penicillin G 7 (benzylpenicillin). Initially, three amino 640 medications, comprising a based-nitrogen heterocycle, we acids-L-a-aminoadipic acids, L-cysteine, L-valine are condensed had to be selective and sumarritive, limiting ourselves to most to a tripeptide.46–48 Before the generation of this tripeptide, the This article is licensed under a Open Access Article. Published on 15 December 2020. Downloaded 10/6/2021 4:16:25 PM. Scheme 1 Synthesis of penicilin G 7. 44248 | RSC Adv.,2020,10, 44247–44311 This journal is © The Royal Society of Chemistry 2020 View Article Online Review RSC Advances amino acid L-valine is subjected to epimerization to turn out to be The total synthesis of penicillin V 20 was rst achieved in 49,50 D-valine 3. This tripeptide is called d-(L-a-aminoadipyl)-L- 1948. It started with racemic valine 3, which was effectively cysteine-D-valine (ACV) 4. The above epimerization and conden- converted
Recommended publications
  • Hazardous Substance Fact Sheet
    Right to Know Hazardous Substance Fact Sheet Common Name: DIOXOLANE Synonyms: 1,3-Dioxolan; Formal Glycol; Glycol Methylene Ether CAS Number: 646-06-0 Chemical Name: 1,3-Dioxolane RTK Substance Number: 0791 Date: February 1999 Revision: April 2008 DOT Number: UN 1166 Description and Use EMERGENCY RESPONDERS >>>> SEE BACK PAGE Dioxolane is a clear, colorless liquid with an Ether-like odor. It Hazard Summary is used in lithium batteries and as a solvent for oils, fats, waxes Hazard Rating NJDOH NFPA and dyes. HEALTH - 1 FLAMMABILITY - 3 REACTIVITY - 2 FLAMMABLE AND REACTIVE POISONOUS GASES ARE PRODUCED IN FIRE CONTAINERS MAY EXPLODE IN FIRE Hazard Rating Key: 0=minimal; 1=slight; 2=moderate; 3=serious; Reasons for Citation 4=severe f Dioxolane is on the Right to Know Hazardous Substance List because it is cited by ACGIH, DOT, and NFPA. f Dioxolane can affect you by ingestion and may be absorbed f This chemical is on the Special Health Hazard Substance through the skin. List. f Contact can irritate and burn the skin and eyes with possible eye damage. f Inhaling Dioxolane can irritate the nose and throat causing coughing and wheezing. f Exposure to Dioxolane may damage the nervous system. f Dioxolane may damage the kidneys. f Dioxolane is FLAMMABLE and REACTIVE and a SEE GLOSSARY ON PAGE 5. DANGEROUS FIRE and EXPLOSION HAZARD. FIRST AID Eye Contact f Immediately flush with large amounts of cool water for at Workplace Exposure Limits least 15 minutes, lifting upper and lower lids. Remove ACGIH: The threshold limit value (TLV) is 20 ppm averaged contact lenses, if worn, while flushing.
    [Show full text]
  • Dopamine: a Role in the Pathogenesis and Treatment of Hypertension
    Journal of Human Hypertension (2000) 14, Suppl 1, S47–S50 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh Dopamine: a role in the pathogenesis and treatment of hypertension MB Murphy Department of Pharmacology and Therapeutics, National University of Ireland, Cork, Ireland The catecholamine dopamine (DA), activates two dis- (largely nausea and orthostasis) have precluded wide tinct classes of DA-specific receptors in the cardio- use of D2 agonists. In contrast, the D1 selective agonist vascular system and kidney—each capable of influenc- fenoldopam has been licensed for the parenteral treat- ing systemic blood pressure. D1 receptors on vascular ment of severe hypertension. Apart from inducing sys- smooth muscle cells mediate vasodilation, while on temic vasodilation it induces a diuresis and natriuresis, renal tubular cells they modulate sodium excretion. D2 enhanced renal blood flow, and a small increment in receptors on pre-synaptic nerve terminals influence nor- glomerular filtration rate. Evidence is emerging that adrenaline release and, consequently, heart rate and abnormalities in DA production, or in signal transduc- vascular resistance. Activation of both, by low dose DA tion of the D1 receptor in renal proximal tubules, may lowers blood pressure. While DA also binds to alpha- result in salt retention and high blood pressure in some and beta-adrenoceptors, selective agonists at both DA humans and in several animal models of hypertension. receptor classes have been studied in the treatment of
    [Show full text]
  • AHFS Pharmacologic-Therapeutic Classification System
    AHFS Pharmacologic-Therapeutic Classification System Abacavir 48:24 - Mucolytic Agents - 382638 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Acitretin 84:92 - Skin and Mucous Membrane Agents, Abaloparatide 68:24.08 - Parathyroid Agents - 317036 Aclidinium Abatacept 12:08.08 - Antimuscarinics/Antispasmodics - 313022 92:36 - Disease-modifying Antirheumatic Drugs - Acrivastine 92:20 - Immunomodulatory Agents - 306003 4:08 - Second Generation Antihistamines - 394040 Abciximab 48:04.08 - Second Generation Antihistamines - 394040 20:12.18 - Platelet-aggregation Inhibitors - 395014 Acyclovir Abemaciclib 8:18.32 - Nucleosides and Nucleotides - 381045 10:00 - Antineoplastic Agents - 317058 84:04.06 - Antivirals - 381036 Abiraterone Adalimumab; -adaz 10:00 - Antineoplastic Agents - 311027 92:36 - Disease-modifying Antirheumatic Drugs - AbobotulinumtoxinA 56:92 - GI Drugs, Miscellaneous - 302046 92:20 - Immunomodulatory Agents - 302046 92:92 - Other Miscellaneous Therapeutic Agents - 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous - Adapalene 84:92 - Skin and Mucous Membrane Agents, Acalabrutinib 10:00 - Antineoplastic Agents - 317059 Adefovir Acamprosate 8:18.32 - Nucleosides and Nucleotides - 302036 28:92 - Central Nervous System Agents, Adenosine 24:04.04.24 - Class IV Antiarrhythmics - 304010 Acarbose Adenovirus Vaccine Live Oral 68:20.02 - alpha-Glucosidase Inhibitors - 396015 80:12 - Vaccines - 315016 Acebutolol Ado-Trastuzumab 24:24 - beta-Adrenergic Blocking Agents - 387003 10:00 - Antineoplastic Agents - 313041 12:16.08.08 - Selective
    [Show full text]
  • Hypertensive Crises 8.25
    Hypertensive Crises 8.25 Hypertension crises secondary to monoamine oxidase inhibitor–tyramine interactions Monoamine oxidase inhibitor therapy Impaired degradation of intracellular amines Ingestion of (epinephrine, norepinephrine, dopamine) tyramine-containing food Accumulation of catecholamines in Hepatic monamine nerve terminal storage granules oxidase inhibition with decreased Increased circulating oxidative metabolism tyramine level of tyramine Massive release of catecholamines Tachyarrhythmias Vasoconstriction (increased systemic vascular resistance) Severe paroxysm of hypertension Hypertensive encephalopathy Acute hypertensive heart failure with pulmonary edema Intracerebral hemorrhage (Fig. 8-21) (Figs. 8-24 and 8-25) FIGURE 8-32 Hypertensive crises secondary to monoamine oxidase inhibitor–tyramine interactions. Severe paroxysmal hypertension complicated by intracerebral or subarachnoid hemorrhage, hypertensive encephalopathy, or acute hypertensive heart failure can occur in patients treated with monoamine oxidase (MOA) inhibitors after ingestion of certain drugs or tyramine- containing foods [48,49]. Because MAO is required for degradation of intracellular amines, including epinephrine, norepinephrine, and dopamine, MAO inhibitors lead to accumulation of catecholamines within storage granules in nerve terminals. The amino acid tyramine is a potent inducer of neurotransmitter release from nerve terminals. As a result of inhibition of hepatic MAO, ingested tyramine escapes oxidative degradation in the liver. In addition, the high circulating levels of tyramine provoke massive catecholamine release from nerve terminals, resulting in vasoconstriction and a paroxysm of severe hypertension. A hyper- adrenergic syndrome resembling pheochromocytoma then ensues. Symptoms include severe pounding headache, flushing or pallor, profuse diaphoresis, nausea, vomiting, and extreme prostration. The mean increase in blood pressure is 55 mm Hg systolic and 30 mm Hg diastolic [49]. The duration of the attacks varies from 10 minutes to 6 hours.
    [Show full text]
  • A Review on Electrochemical Properties of Choline Chloride Based Eutectic Solvent in Mineral Processing
    JASEM ISSN 1119 -8362 Full-text Available Online at J. Appl. Sci. Environ. Manage. August 2017 Vol. 21 (5) 991-998 www.ajol.info and All rights reserved www.bioline.org.br/ja A Review on Electrochemical Properties of Choline Chloride Based Eutectic Solvent in Mineral Processing *1OBETEN, ME; UGI, BU; ALOBI, NO Department of Chemical Sciences, Cross River University of Technology, P. M. B. 1123 Calabar - Cross River State, Nigeria. ABSTRACT: Our review highlights the most recent developments in ionic liquid (IL) chemistry where the “well-known” description of IL properties sometimes proves to be inaccurate. However, in the authors’ opinion, all these new research developments concerning ionic liquid properties serve to update knowledge on the typical physical and chemical properties of ILs, which is significant to both theoretical research and industrial applications. Therefore, rather than attempting to give a comprehensive overview of ionic liquid chemistry, the paper presents an opportunity to understand deep eutectic solvents (DES) through a more complete and accurate view . © JASEM https://dx.doi.org/10.4314/jasem.v21i5.29 Keywords : Eutectic; Solvents; Electrochemistry; Ionic Liquids; purification; Ethylene glycol. Since environmental pollution caused by chemical mixed with different hydrogen bond donors (HBDs) and energy industries has increased for several such as urea, ethylene glycol, acetamide or decades, there is high expectation from scientists and hexanediol (type IV DES). engineers to design sustainable chemical processes, to generate less harmful materials and more Owing to its low cost, biodegradability and low environmentally friendly sources of energy toxicity, ChCl was widely used as an organic salt to production.
    [Show full text]
  • LF-117708-01 Hydralazine 20Mg-Ml Injection V7
    Package leaflet: Information for the patient 28055763 syringe, this is called an intravenous injection or; • A restriction of movement in part of the intestine; LF-117708-01 - it may be diluted further and injected very slowly • A deficiency of certain white blood cells which into your vein through a drip (intravenous infusion). can result in fever and ulceration of the mouth The recommended dose is 5 to 10 mg by and throat; intravenous injection, and will be repeated if • An increased number of white blood cells; necessary after 20 to 30 minutes. • Enlargement of the spleen; Hydralazine 20mg Powder for Concentrate for Solution for Injection/Infusion • A reduction in the number of red and white blood Your blood pressure will be taken whilst you cells and platelets in the blood; Hydralazine hydrochloride are receiving treatment and the dose adjusted • Depression; to make sure that you have gradual fall in your Read all of this leaflet carefully before you start • have been told you are a slow acetylator • Seeing or hearing things which are not really blood pressure to normal levels. taking this medicine because it (this means that your body handles some there (hallucinations); contains important information for you medicines more slowly than other people); If you are given more medicine than you should • Inflammation of the nerves which may cause weakness - Keep this leaflet. You may need to read it again. • suffer from any serious liver or kidney problems; As this medicine is given to you in hospital it is very or numbness especially in your fingers and toes; - If you have any further questions ask your • have blockage of one or more arteries that supply unlikely that an overdose will happen.
    [Show full text]
  • Student Number: 201477310
    COPYRIGHT AND CITATION CONSIDERATIONS FOR THIS THESIS/ DISSERTATION o Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. o NonCommercial — You may not use the material for commercial purposes. o ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. How to cite this thesis Surname, Initial(s). (2012) Title of the thesis or dissertation. PhD. (Chemistry)/ M.Sc. (Physics)/ M.A. (Philosophy)/M.Com. (Finance) etc. [Unpublished]: University of Johannesburg. Retrieved from: https://ujcontent.uj.ac.za/vital/access/manager/Index?site_name=Research%20Output (Accessed: Date). Metabolomics, Physicochemical Properties and Mycotoxin Reduction of Whole Grain Ting (a Southern African fermented food) Produced via Natural and Lactic acid bacteria (LAB) fermentation A Thesis submitted to the Faculty of Science, University of Johannesburg, South Africa In partial fulfilment of the requirement for the award of a Doctoral Degree in Food Technology By OLUWAFEMI AYODEJI ADEBO STUDENT NUMBER: 201477310 Supervisor : Dr. E. Kayitesi Co-supervisor: Prof. P. B. Njobeh October 2018 EXECUTIVE SUMMARY Drought and challenges related to climate change are some of the issues facing sub-Saharan Africa countries, with dire consequences on agriculture and food security. Due to this prevailing situation, drought and climate resistant crops like sorghum (Sorghum bicolor (L) Moench) can adequately contribute to food security. The versatility and importance of sorghum is well reflected in its use as a major food source for millions of people in sub-Saharan Africa.
    [Show full text]
  • Toxicological Profile for Hydrazines. US Department Of
    TOXICOLOGICAL PROFILE FOR HYDRAZINES U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry September 1997 HYDRAZINES ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. HYDRAZINES iii UPDATE STATEMENT Toxicological profiles are revised and republished as necessary, but no less than once every three years. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE, E-29 Atlanta, Georgia 30333 HYDRAZINES vii CONTRIBUTORS CHEMICAL MANAGER(S)/AUTHOR(S): Gangadhar Choudhary, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Hugh IIansen, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Steve Donkin, Ph.D. Sciences International, Inc., Alexandria, VA Mr. Christopher Kirman Life Systems, Inc., Cleveland, OH THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS: 1 . Green Border Review. Green Border review assures the consistency with ATSDR policy. 2 . Health Effects Review. The Health Effects Review Committee examines the health effects chapter of each profile for consistency and accuracy in interpreting health effects and classifying end points. 3. Minimal Risk Level Review. The Minimal Risk Level Workgroup considers issues relevant to substance-specific minimal risk levels (MRLs), reviews the health effects database of each profile, and makes recommendations for derivation of MRLs. HYDRAZINES ix PEER REVIEW A peer review panel was assembled for hydrazines. The panel consisted of the following members: 1. Dr.
    [Show full text]
  • US EPA, Inert (Other) Pesticide Ingredients in Pesticide Products
    Inert Ingredients ordered by CAS Number Updated August 2004 CAS PREFIX NAME List No. 50-21-5 Lactic acid 4B 50-70-4 Sorbitol 4A 50-81-7 L- Ascorbic acid 4A 50-99-7 Dextrose 4A 51-03-6 Piperonyl butoxide 3 51-05-8 Procaine hydrochloride 3 51-55-8 Atropine 3 52-51-7 2- Bromo-2-nitro-propane-1,3-dio 3 54-21-7 Sodium salicylate 3 56-81-5 Glycerol (glycerin) 1,2,3 propanetriol 4A 56-86-0 L- Glutamic acid 3 56-95-1 Chlorhexidine diacetate 3 57-10-3 Hexadecanoic acid 4A 57-11-4 Stearic acid 4A 57-13-6 Urea 4A 57-48-7 D- Fructose 4B 57-50-1 Sugar 4A 57-55-6 Propylene glycol 4B 57-88-5 (3.beta.)- Cholest-5-en-3-ol 4B 58-08-2 1H- Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl- 4B 58-56-0 Thiamine mononitrate 4B 58-85-5 Biotin 3 58-86-6 D- Xylose 4B 58-95-7 Vitamin E acetate 3 59-30-3 Folic acid 4B 59-40-5 N-(2- Quinoxalinyl)sulfanilide 3 59-67-6 Nicotinic acid 3 60-00-4 Ethylenediaminetetraacetic acid (EDTA) 4B 60-12-8 Benzeneethanol 3 60-29-7 Ethane, 1,1'-oxybis- 3 60-33-3 Linoleic acid 3 61-73-4 C.I. Basic Blue 9 3 62-33-9 Ethylenediaminetetraacetic acid (EDTA), calcium4B 62-54-4 Acetic acid, calcium salt 4A 63-42-3 D-(+)-Lactose 4A 63-68-3 L- Methionine 4B 64-02-8 Ethylenediaminetetraacetic acid (EDTA), tetraso4B 64-17-5 Ethanol 4B 64-18-6 Formic acid 3 64-19-7 Acetic acid 4B 64-86-8 Colchicine 3 65-85-0 Benzoic acid 4B 66-71-7 1,10- Phenanthroline 3 67-03-8 Thiamin hydrochloride 3 67-43-6 1,1,4,7,7- Diethylenetriaminepentaacetic acid 3 67-48-1 Choline chloride 4B 67-56-1 Methyl alcohol 3 67-63-0 2- Propanol 4B 67-64-1 Acetone 3 67-68-5 Dimethyl
    [Show full text]
  • Guideline for Preoperative Medication Management
    Guideline: Preoperative Medication Management Guideline for Preoperative Medication Management Purpose of Guideline: To provide guidance to physicians, advanced practice providers (APPs), pharmacists, and nurses regarding medication management in the preoperative setting. Background: Appropriate perioperative medication management is essential to ensure positive surgical outcomes and prevent medication misadventures.1 Results from a prospective analysis of 1,025 patients admitted to a general surgical unit concluded that patients on at least one medication for a chronic disease are 2.7 times more likely to experience surgical complications compared with those not taking any medications. As the aging population requires more medication use and the availability of various nonprescription medications continues to increase, so does the risk of polypharmacy and the need for perioperative medication guidance.2 There are no well-designed trials to support evidence-based recommendations for perioperative medication management; however, general principles and best practice approaches are available. General considerations for perioperative medication management include a thorough medication history, understanding of the medication pharmacokinetics and potential for withdrawal symptoms, understanding the risks associated with the surgical procedure and the risks of medication discontinuation based on the intended indication. Clinical judgement must be exercised, especially if medication pharmacokinetics are not predictable or there are significant risks associated with inappropriate medication withdrawal (eg, tolerance) or continuation (eg, postsurgical infection).2 Clinical Assessment: Prior to instructing the patient on preoperative medication management, completion of a thorough medication history is recommended – including all information on prescription medications, over-the-counter medications, “as needed” medications, vitamins, supplements, and herbal medications. Allergies should also be verified and documented.
    [Show full text]
  • Hydralazine Hydrochloride Tablets, USP8073301/1120Rx Only
    HYDRALAZINE HYDROCHLORIDE- hydralazine hydrochloride tablet, film coated American Health Packaging ---------- Hydralazine Hydrochloride Tablets, USP 8073301/1120 Rx only DESCRIPTION HydrALAZINE hydrochloride, USP, is an antihypertensive, for oral administration. Its chemical name is 1-hydrazinophthalazine monohydrochloride, and its structural formula is: HydrALAZINE hydrochloride, USP is a white to off-white, odorless crystalline powder. It is soluble in water, slightly soluble in alcohol, and very slightly soluble in ether. It melts at about 275°C, with decomposition, and has a molecular weight of 196.64. Each tablet for oral administration contains 10 mg, 25 mg, 50 mg, or 100 mg hydrALAZINE hydrochloride, USP. Tablets also contain FD&C Red #40/Allura Red AC Aluminum Lake, hypromellose, lactose anhydrous, light mineral oil, microcrystalline cellulose, magnesium stearate, pregelatinized starch, sodium lauryl sulfate, and titanium dioxide. CLINICAL PHARMACOLOGY Although the precise mechanism of action of hydrALAZINE is not fully understood, the major effects are on the cardiovascular system. HydrALAZINE apparently lowers blood pressure by exerting a peripheral vasodilating effect through a direct relaxation of vascular smooth muscle. HydrALAZINE, by altering cellular calcium metabolism, interferes with the calcium movements within the vascular smooth muscle that are responsible for initiating or maintaining the contractile state. The peripheral vasodilating effect of hydrALAZINE results in decreased arterial blood pressure (diastolic more than systolic); decreased peripheral vascular resistance; and an increased heart rate, stroke volume, and cardiac output. The preferential dilatation of arterioles, as compared to veins, minimizes postural hypotension and promotes the increase in cardiac output. HydrALAZINE usually increases renin activity in plasma, presumably as a result of increased secretion of renin by the renal juxtaglomerular cells in response to reflex sympathetic discharge.
    [Show full text]
  • EZ Speed Strip Safety Data Sheet
    Date Printed: 10/14/2020 Page 1 / 6 Safety Data Sheet 1. Identification Product Name: EZ Speed Strip Revision Date: 10/14/2020 Product Identifier: 11212500 Recommended Use: Paint Remover/Strip Supplier: Emergency Telephone: Chemtrec: +1-800-424-9300 (USA) Kop-Coat Marine Group Chemtrec: +1 703-527-3887 (Intl.) 36 Pine Street 24 hrs./day, 7 days/week Rockaway, NJ, 07866, USA Poison Control: 1-800-222-1222 1-800-221-4466 (non - emergency matters) 24 Hour Hotline: 847-367-7700 2. Hazard Identification Classification Symbol(s) of Product Signal Word Danger Possible Hazards 87% of the mixture consists of ingredient(s) of unknown acute toxicity. GHS HAZARD STATEMENTS Acute Toxicity, Inhalation, category 4 H332 Harmful if inhaled. Eye Irritation, category 2A H319 Causes serious eye irritation. Flammable Liquid, category 2 H225 Highly flammable liquid and vapour. STOT, single exposure, category 3, NE H336 May cause drowsiness or dizziness. GHS LABEL PRECAUTIONARY STATEMENTS P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P261 Avoid breathing dust/fume/gas/mist/vapors/spray. P264 Wash hands thoroughly after handling. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/protective clothing/eye protection/face protection. P303+P361+P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/ shower. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do.
    [Show full text]